Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Dynavax Technologies Corporation stock

Learn how to easily invest in Dynavax Technologies Corporation stock.

Dynavax Technologies Corporation is a drug manufacturers-specialty & generic business based in the US. Dynavax Technologies Corporation shares (DVAX) are listed on the NASDAQ and all prices are listed in US Dollars. Dynavax Technologies Corporation employs 311 staff and has a trailing 12-month revenue of around $732.1 million.

How to buy Dynavax Technologies Corporation stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – DVAX. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Promoted for options trading

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Dynavax Technologies Corporation stock price (NASDAQ: DVAX)

Use our graph to track the performance of DVAX stocks over time.

Dynavax Technologies Corporation shares at a glance

Information last updated 2023-01-24.
Latest market close$11.84
52-week range$7.26 - $17.48
50-day moving average $11.62
200-day moving average $11.72
Wall St. target price$23.20
PE ratio 4.9915
Dividend yield $0 (0%)
Earnings per share (TTM) $2.34

Buy Dynavax Technologies Corporation stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Dynavax Technologies Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dynavax Technologies Corporation price performance over time

Historical closes compared with the close of $11.84 from 2023-01-27

1 week (2023-01-23) 2.25%
1 month (2022-12-30) 11.28%
3 months (2022-10-28) 0.94%
6 months (2022-07-29) -17.66%
1 year (2022-01-28) -6.03%
2 years (2021-01-29) 87.64%
3 years (2020-01-30) 137.27%
5 years (2018-01-30) 16.4

Is Dynavax Technologies Corporation stock undervalued or overvalued?

Valuing Dynavax Technologies Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Dynavax Technologies Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Dynavax Technologies Corporation's P/E ratio

Dynavax Technologies Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 5x. In other words, Dynavax Technologies Corporation shares trade at around 5x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Dynavax Technologies Corporation's EBITDA

Dynavax Technologies Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $313.2 million.

The EBITDA is a measure of a Dynavax Technologies Corporation's overall financial performance and is widely used to measure a its profitability.

Dynavax Technologies Corporation financials

Revenue TTM $732.1 million
Operating margin TTM 42.23%
Gross profit TTM $235 million
Return on assets TTM 20.14%
Return on equity TTM 114.48%
Profit margin 44.42%
Book value $3.92
Market capitalisation $1.5 billion

TTM: trailing 12 months

Dynavax Technologies Corporation share dividends

We're not expecting Dynavax Technologies Corporation to pay a dividend over the next 12 months.

Have Dynavax Technologies Corporation's shares ever split?

Dynavax Technologies Corporation's shares were split on a 1:10 basis on 9 November 2014. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Dynavax Technologies Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Dynavax Technologies Corporation shares which in turn could have impacted Dynavax Technologies Corporation's share price.

Dynavax Technologies Corporation share price volatility

Over the last 12 months, Dynavax Technologies Corporation's shares have ranged in value from as little as $7.26 up to $17.48. A popular way to gauge a stock's volatility is its "beta".

DVAX.US volatility(beta: 1.43)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Dynavax Technologies Corporation's is 1.428. This would suggest that Dynavax Technologies Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Dynavax Technologies Corporation overview

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd. ; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996.

Frequently asked questions

What percentage of Dynavax Technologies Corporation is owned by insiders or institutions?
Currently 0.289% of Dynavax Technologies Corporation shares are held by insiders and 92.792% by institutions.
How many people work for Dynavax Technologies Corporation?
Latest data suggests 311 work at Dynavax Technologies Corporation.
When does the fiscal year end for Dynavax Technologies Corporation?
Dynavax Technologies Corporation's fiscal year ends in December.
Where is Dynavax Technologies Corporation based?
Dynavax Technologies Corporation's address is: 2100 Powell Street, EmeryVille, CA, United States, 94608
What is Dynavax Technologies Corporation's ISIN number?
Dynavax Technologies Corporation's international securities identification number is: US2681582019
What is Dynavax Technologies Corporation's CUSIP number?
Dynavax Technologies Corporation's Committee on Uniform Securities Identification Procedures number is: 268158102

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site